Skip to content

Clinical trials

Phase 4 Lipodystrophy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lipodystrophy Phase: Phase 4 Country / region: United States Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20021
20061
20101
20111
20182

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Glaxo Wellcome2
Aegerion Pharmaceuticals, Inc.1
Clinical Alliance for Research & Education - Infectious Diseases, LLC.1
Dermatology Cosmetic Laser Medical Associates of La Jolla, Inc.1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
The Cleveland Clinic1
The Maas Clinic1
Tufts Medical Center1
University of Texas Southwestern Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lipodystrophy10
HIV Infections7
Insulin Resistance2
Emaciation1
Facies1
Lipodystrophy, Congenital Generalized1
Mitochondrial Diseases1
Skin Abnormalities1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.